Paxlovid Kit
Pricing Report NDC 0069-0521-11
Current Package Pricing Information
The current wholesale acquisition cost for Paxlovid (NDC 0069-0521-11) is $133.54127 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.
As a a human prescription drug provided by Pfizer Laboratories Div Pfizer Inc, this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACK * 6 TABLET, FILM COATED in 1 BLISTER PACK (0069-2085-06) * 5 TABLET, FILM COATED in 1 BLISTER PACK (0069-1735-05) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $133.54127 Per EA
Historical Pricing Trends & Acquisition Cost Benchmarks
Since Nov 2025, the NADAC wholesale price for (NDC ) has moved within a range of $130.25000 to $134.15750 per EA. Over this 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
$130.2500 - $134.1575
3.00% Variance
0.46%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Jun 17, 2026 | $133.54127 | EA | C/I - Chain or Independent Pharmacy | Code 1 | B - Brand |
| Jan 01, 2026 | $134.15750 | EA | C/I - Chain or Independent Pharmacy | Code 2 | B - Brand |
| Jan 01, 2026 | $134.15750 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Jan 01, 2026 | $134.15750 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Dec 17, 2025 | $130.25000 | EA | C/I - Chain or Independent Pharmacy | Code 1 | B - Brand |
| Nov 19, 2025 | $130.32084 | EA | C/I - Chain or Independent Pharmacy | Code 1 | B - Brand |
Pricing Methodology Legend
- Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
- Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 4: The NADAC was carried forward from the previous file.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
